Clinical Trial Update: Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tandem autologous stem cell transplant with melphalan followed by melphalan and bortezomib in adults with multiple myeloma; results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (Velcade) (Bortezomib)
• Melphalan (Alkeran) (melphalan)

Snippet

Sponsor: Hackensack Meridian Health | Conditions: Multiple Myeloma, Auto Stem Cell Transplant | Phase 3 | Status: COMPLETED | Results posted: 2025-09-17